Medicare Enrolled

Dr. Craig Wlodarek, M.D

Neurology · Hinsdale, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
908 N ELM ST STE 110, Hinsdale, IL 60521
6309868770
In practice since 2007 (19 years)
NPI: 1851442230 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wlodarek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wlodarek? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wlodarek

Dr. Craig Wlodarek is a neurology specialist in Hinsdale, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Wlodarek performed 1,185 Medicare services across 965 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wlodarek received a total of $22,242 from 77 pharmaceutical and/or device companies across 1079 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wlodarek is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 22% volume in IL $22,242 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,185
Medicare services
Top 22% in IL for neurology
965
Unique beneficiaries
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~62 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
331 $93 $229
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
199 $79 $460
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
170 $64 $157
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
135 $83 $235
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
133 $128 $359
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
70 $110 $750
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
36 $69 $219
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
30 $8 $20
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
27 $179 $1,500
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
15 $138 $307
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
15 $65 $151
Sed rate test (inflammation marker)
This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body.
12 $3 $14
Nerve conduction study, 3-4 tests
A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function.
12 $92 $625
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$22,242
Total received (2018-2024)
Avg $3,177/year across 7 years
Top 13% in IL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
77
Companies
1,079
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,595 (83.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,303 (14.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$344 (1.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,059
2023
$4,170
2022
$5,536
2021
$2,484
2020
$1,174
2019
$2,136
2018
$2,684

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$817
Supernus Pharmaceuticals, Inc.
$538
Biogen, Inc.
$366
Novartis Pharmaceuticals Corporation
$356
MDD US Operations, LLC
$273
Teva Pharmaceuticals USA, Inc.
$229
Lilly USA, LLC
$212
UCB, Inc.
$194
Genentech USA, Inc.
$144
Celgene Corporation
$104
SK Life Science, Inc.
$102
Takeda Pharmaceuticals U.S.A., Inc.
$94
BANNER LIFE SCIENCES, LLC
$79
Lundbeck LLC
$79
ARGENX US, INC.
$59
Neurocrine Biosciences, Inc.
$54
Kyowa Kirin, Inc.
$48
Eisai Inc.
$44
PFIZER INC.
$36
ACADIA Pharmaceuticals Inc
$28
CATALYST PHARMACEUTICALS, INC.
$27
Amgen Inc.
$25
Ipsen Biopharmaceuticals, Inc
$25
Otsuka America Pharmaceutical, Inc.
$22
TG Therapeutics, Inc.
$19
Alexion Pharmaceuticals, Inc.
$18
NEUROPACE, INC.
$18
SCILEX PHARMACEUTICALS INC.
$18
Currax Pharmaceuticals LLC
$16
Abbott Laboratories
$15
Top 3 companies account for 42.4% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$4,121
Biogen, Inc.
$2,567
Supernus Pharmaceuticals, Inc.
$1,568
Teva Pharmaceuticals USA, Inc.
$1,515
AbbVie Inc.
$1,226
Novartis Pharmaceuticals Corporation
$1,113
Lilly USA, LLC
$1,009
Genentech USA, Inc.
$584
UCB, Inc.
$573
SK Life Science, Inc.
$504
Alexion Pharmaceuticals, Inc.
$478
Lundbeck LLC
$383
Amgen Inc.
$371
MDD US Operations, LLC
$354
Allergan, Inc.
$338
Neurocrine Biosciences, Inc.
$318
PFIZER INC.
$303
Biohaven Pharmaceutical Holding Company Ltd.
$297
Eisai Inc.
$296
GENZYME CORPORATION
$293
Sunovion Pharmaceuticals Inc.
$288
LivaNova USA, Inc.
$266
Acorda Therapeutics, Inc
$221
Kyowa Kirin, Inc.
$220
Takeda Pharmaceuticals U.S.A., Inc.
$209
Biohaven Pharmaceuticals, Inc.
$188
EMD Serono, Inc.
$184
AbbVie, Inc.
$171
Celgene Corporation
$167
ARGENX US, INC.
$158
Akcea Therapeutics, Inc.
$147
BANNER LIFE SCIENCES, LLC
$118
Avanir Pharmaceuticals, Inc.
$101
SANOFI-AVENTIS U.S. LLC
$92
EISAI INC.
$90
Amneal Pharmaceuticals LLC
$89
US WorldMeds, LLC
$78
ACADIA Pharmaceuticals Inc
$73
Zyla Life Sciences
$73
Abbott Laboratories
$63
Catalyst Pharmaceuticals, Inc.
$58
Otsuka America Pharmaceutical, Inc.
$56
Allergan Inc.
$55
GE Healthcare
$55
Grifols USA, LLC
$49
TG THERAPEUTICS, INC.
$45
Bausch Health US, LLC
$44
Ipsen Biopharmaceuticals, Inc
$39
Medtronic USA, Inc.
$38
Upsher-Smith Laboratories LLC
$37
CSL Behring
$34
Egalet US Inc
$30
Currax Pharmaceuticals LLC
$29
Exeltis, USA Inc.
$28
CATALYST PHARMACEUTICALS, INC.
$27
Janssen Pharmaceuticals, Inc
$27
E.R. Squibb & Sons, L.L.C.
$25
Collegium Pharmaceutical, Inc.
$25
Vertical Pharmaceuticals, LLC
$23
GRT US Holding, Inc.
$23
Impax Laboratories, Inc.
$21
Bayer HealthCare Pharmaceuticals Inc.
$19
TG Therapeutics, Inc.
$19
IMPEL PHARMACEUTICALS INC.
$19
NEUROPACE, INC.
$18
SCILEX PHARMACEUTICALS INC.
$18
Avion Pharmaceuticals
$18
Averitas Pharma Inc.
$18
JAZZ PHARMACEUTICALS INC.
$18
Greenwich Biosciences, Inc.
$17
Boston Scientific Corporation
$17
Assertio Therapeutics, Inc.
$17
AstraZeneca Pharmaceuticals LP
$16
PORTOLA PHARMACEUTICALS, INC.
$16
Adamas Pharmaceuticals, Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$14
Corium, LLC
$6
Top 3 companies account for 37.1% of all-time payments
Associated products mentioned in payments ›
ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aduhelm · Aimovig · Apokyn · Austedo XR · BAFIERTAM · BOTOX · BRILINTA · BRIUMVI · Betaseron · Briviact · CAMBIA · COMIRNATY · COPAXONE · DUOPA · DYSPORT · Dhivy · Duopa · Dysport · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FYCOMPA · Fycompa · GAMMAGARD · GENERAL DBS · GILENYA · GOCOVRI · Gamunex-C · General - DBS · HYQVIA · Hizentra · INBRIJA · INFINITY · INGREZZA · INTELLIS · Infinity DBS Pulse Generators · KESIMPTA · LEMTRADA · Leqembi · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · ONFI · ONZETRA XSAIL · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · PLEGRIDY · PURIFIED CORTROPHIN GEL · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · Qelbree · Qutenza · REXULTI · RNS Neurostimulator Kit · RYTARY · Rebif · Rystiggo · SOLIRIS · SPRIX · Soliris · TECFIDERA · TEGSEDI · TROKENDI XR · TYSABRI · Trudhesa · Tysabri · UBRELVY · ULTOMIRIS · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XCOPRI · Xadago · ZAVZPRET · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (84%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Hinsdale?
Compare neurologists in the Hinsdale area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
620
Per 100K population
66.9
County median income
$110,502
Nearest hospital
UCHICAGO MEDICINE ADVENTHEALTH HINSDALE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wlodarek is a clinical cardiology specialist, with above-average Medicare volume (top 22% in IL), with low-engagement industry engagement in the top 13% of IL peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wlodarek experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Wlodarek performed 331 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wlodarek receive payments from pharmaceutical companies?
Yes. Dr. Wlodarek received a total of $22,242 from 77 companies across 1,079 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wlodarek's costs compare to other neurologists in Hinsdale?
Dr. Wlodarek's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wlodarek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →